San Francisco, CA, January 12, 2021 — The collaboration between Feel Therapeutics, Inc., SCOR and Gothaer has been recognized with the Thought Leader Award 2020 at the “Digital Insurance conference”, an event supported by Süddeutsche Zeitung & Google in Germany. The independent board of Trustees was looking for innovative concepts that bring new things to insurance customers and focus on real relief and service improvement.
Feel's partnership with insurance leaders Gothaer Life Insurance and SCOR uses the Feel Program to prevent and treat occupational disability caused by mental health disorders, such as stress or burn-out. Mental health disorders are one of the main causes of incapacity to work in Germany, and the number of sick days due to mental illness has been rising continuously since 1997. However, early intervention can help reduce absenteeism. Feel is a holistic mental health program to improve a person’s emotional state by bringing objective data for the first time and delivering on-time mental health support.
George Eleftheriou, CEO and Co-Founder of Feel Therapeutics, said: “Thank you to everyone who has made this a reality and a special thank you to our amazing partners. We are truly looking forward to growing this meaningful partnership in the future and empower mental health support for everyone in need!”
This partnership has exceeded expectations in both interest and engagement in the program, with 75% of participants completing the program and taking part in all online coaching sessions, showcasing the need for preventative mental health solutions. There was also positive feedback to the insurance agents, but above all, no complaints. The participants answered a questionnaire at the beginning, middle, and end of the program, showing that general life satisfaction improved significantly. Participants stated that they gained a greater understanding of their emotions and behavior patterns through using Feel.
Feel Therapeutics, Inc. is developing Digital Biomarkers and Therapeutics to bring objective data and measurement in the way we diagnose, manage, and care for Mental Health. The company is backed by top-tier investors (Felicis, Anthemis, SOSV) and has partnerships with large pharmaceutical companies to develop novel digital biomarkers and bring digital health solutions to market as standalone programs or alongside medications. Feel Therapeutics is headquartered in San Francisco, with additional offices in Europe. For more information, visit http://www.feeltherapeutics.com or contact us at info@feeltherapeutics.com.
